The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multidimensional spatial characterization of the tumor microenvironment (TME) in synchronous melanoma metastases (SMM) to yield insights into mixed responses to therapy in metastatic melanoma (MM) patients (pts).
 
Alexandre Reuben
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center (Inst)
Travel, Accommodations, Expenses - NanoString Technologies
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics
 
Christine Spencer
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center (Inst)
 
Giang Ong
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Kristi Barker
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Peter A. Prieto
No Relationships to Disclose
 
Christopher Vellano
Research Funding - NanoString Technologies
 
Jinho Lee
No Relationships to Disclose
 
Courtney Hudgens
No Relationships to Disclose
 
Meredith Ann McKean
No Relationships to Disclose
 
Vancheswaran Gopalakrishnan
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center (Inst)
 
Robert Szczepaniak Sloane
No Relationships to Disclose
 
Sangeetha Reddy
No Relationships to Disclose
 
Chris Merritt
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Joseph M Beechem
Employment - NanoString Technologies
Leadership - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Genentech (Inst)
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; Immunome; Myriad Genetics; PTV Sciences; Spindletop Ventures
Honoraria - Allostery; AstraZeneca; Immunome; Isis Pharmaceuticals; Lilly; Novartis; Nuevolution; Symphony Evolution
Consulting or Advisory Role - Adventis Health; Allostery; AstraZeneca; Catena; Critical Outcome Technologies; Isis Pharmaceuticals; Lilly; MedImmune; Millennium; Novartis; Nuevolution; Precision Medicine Research Associates, LLC; Provista Diagnostics; SignalChem; Symphony Evolution; Tarveda Therapeutics; Tau Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; Critical Outcome Technologies; Illumina; Karus Therapeutics; Komipharm; Millennium; NanoString Technologies
Patents, Royalties, Other Intellectual Property - HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - Allostery; AstraZeneca; Immunome; Isis Pharmaceuticals; Lilly; MedImmune; Novartis; Pfizer; Symphony Evolution
 
Jennifer Ann Wargo
Leadership - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Honoraria - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Consulting or Advisory Role - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Speakers' Bureau - Novartis; Genetech
Research Funding - BMS; Genetech; Novartis; GSK (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina